United StatesÚltimas notícias

Penguin Solutions (NASDAQ:PENG) reported its financial results for the second quarter of fiscal 2026 on Wednesday, April 1.

VSee Health (NASDAQ:VSEE) reported its financial and operational results for the fiscal year ended December 31, 2025, on Wednesday, April 1, 2026.

WTW (NASDAQ:WTW), a leading global advisory, broking, and solutions company, announced on Wednesday, April 1, 2026, that it has successfully completed the acquisition of FlowStone Partners.

Largo (NASDAQ:LGO) reported its financial and operational results for the fourth quarter and full year ended December 31, 2025, on Wednesday, April 1, 2026.

Eli Lilly and Company (NYSE:LLY) announced on Wednesday, April 1, 2026, that the U.S. Food and Drug Administration (FDA) has approved Foundayo™ (orforglipron) for chronic weight management in adults with obesity, or those who are overweight with at least one weight-related condition.

UniFirst (NYSE:UNF) reported financial results for its second quarter of fiscal 2026, ended February 28, 2026, on Wednesday, April 1.

Lamb Weston Holdings (NYSE:LW) announced its financial results for the third quarter of fiscal 2026 on Wednesday, April 1, 2026.

RenX Enterprises (NASDAQ:RENX) announced its financial results for the fiscal year ended December 31, 2025, on Wednesday, April 1, 2026.

FitLife Brands (NASDAQ:FTLF) announced its financial results for the fourth quarter and full year ended December 31, 2025, on Wednesday, April 1, 2026. The results highlight a transformative period for the Omaha-based company, largely defined by the successful integration and rapid scaling of the Irwin acquisition.

SES AI (NYSE:SES), a global leader in the development and manufacturing of AI-enhanced high-performance lithium-metal and lithium-ion batteries, provided a robust business update for the first quarter of 2026 on Wednesday, April 1.

Scinai Immunotherapeutics (NASDAQ:SCNI) reported its financial and operational results for the fiscal year ended December 31, 2025, on Wednesday, April 1, 2026.

TuHURA Biosciences (NASDAQ:HURA) provided a comprehensive corporate and financial update for the fiscal year ended December 31, 2025, on Wednesday, April 1, 2026.